title: Imiquimod as neoadjuvant treatment for giant keratoacanthoma arising on a background of lupus vulgaris.
authors.affiliation: State Clinic of Dermatology, Hospital of Skin and Venereal Diseases, 124, Delfon Street, Thessaloniki, Greece.
authors.forename: M
authors.initials: M
authors.lastname: Tsikeloudi
authors.forename: A
authors.initials: A
authors.lastname: Lallas
authors.forename: T
authors.initials: T
authors.lastname: Sidiropoulos
authors.forename: V
authors.initials: V
authors.lastname: Chasioti
authors.forename: I
authors.initials: I
authors.lastname: Lefaki
authors.forename: Z
authors.initials: Z
authors.lastname: Apalla
mesh_terms: D000368:Aged; D000634:Aminoquinolines / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D005148:Facial Dermatoses / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D000077271:Imiquimod; D007636:Keratoacanthoma / Q000188:drug therapy* / Q000473:pathology; D008177:Lupus Vulgaris / Q000150:complications*; D008297:Male; D016896:Treatment Outcome
chemical_list: D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod